BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 30379535)

  • 21. Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.
    McCain J; Colón KL; Barrett PC; Monro SMA; Sainuddin T; Roque Iii J; Pinto M; Yin H; Cameron CG; McFarland SA
    Inorg Chem; 2019 Aug; 58(16):10778-10790. PubMed ID: 31386351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
    Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
    J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From Catalysis to Cancer: Toward Structure-Activity Relationships for Benzimidazol-2-ylidene-Derived N-Heterocyclic-Carbene Complexes as Anticancer Agents.
    Lam NYS; Truong D; Burmeister H; Babak MV; Holtkamp HU; Movassaghi S; Ayine-Tora DM; Zafar A; Kubanik M; Oehninger L; Söhnel T; Reynisson J; Jamieson SMF; Gaiddon C; Ott I; Hartinger CG
    Inorg Chem; 2018 Nov; 57(22):14427-14434. PubMed ID: 30406647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on anticancer properties with varying co-ligands in a Ru(II) arene benzimidazole system.
    Pragti ; Nayek S; Singh S; Sonawane A; Grabchev I; Ganguly R; Mukhopadhyay S
    Dalton Trans; 2023 May; 52(21):7104-7118. PubMed ID: 37158792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes.
    Lazić D; Arsenijević A; Puchta R; Bugarčić ŽD; Rilak A
    Dalton Trans; 2016 Mar; 45(11):4633-46. PubMed ID: 26855406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piano-Stool Ruthenium(II) Complexes with Delayed Cytotoxic Activity: Origin of the Lag Time.
    Rafols L; Josa D; Aguilà D; Barrios LA; Roubeau O; Cirera J; Soto-Cerrato V; Pérez-Tomás R; Martínez M; Grabulosa A; Gamez P
    Inorg Chem; 2021 Jun; 60(11):7974-7990. PubMed ID: 33979132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyrazole appended quinoline-BODIPY based arene ruthenium complexes: their anticancer activity and potential applications in cellular imaging.
    Paitandi RP; Sharma V; Singh VD; Dwivedi BK; Mobin SM; Pandey DS
    Dalton Trans; 2018 Dec; 47(48):17500-17514. PubMed ID: 30507985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of intercalation and redox potential in DNA photosensitization by ruthenium(II) polypyridyl complexes: assessment using DNA repair protein tests.
    Gicquel E; Souchard JP; Magnusson F; Chemaly J; Calsou P; Vicendo P
    Photochem Photobiol Sci; 2013 Aug; 12(8):1517-26. PubMed ID: 23835850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photo-induced DNA cleavage and cytotoxicity of a ruthenium(II) arene anticancer complex.
    Brabec V; Pracharova J; Stepankova J; Sadler PJ; Kasparkova J
    J Inorg Biochem; 2016 Jul; 160():149-55. PubMed ID: 26778426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introducing the 4-Phenyl-1,2,3-Triazole Moiety as a Versatile Scaffold for the Development of Cytotoxic Ruthenium(II) and Osmium(II) Arene Cyclometalates.
    Riedl CA; Flocke LS; Hejl M; Roller A; Klose MH; Jakupec MA; Kandioller W; Keppler BK
    Inorg Chem; 2017 Jan; 56(1):528-541. PubMed ID: 27996251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticancer and antibacterial potential of robust Ruthenium(II) arene complexes regulated by choice of α-diimine and halide ligands.
    Zanda E; Busto N; Biancalana L; Zacchini S; Biver T; Garcia B; Marchetti F
    Chem Biol Interact; 2021 Aug; 344():109522. PubMed ID: 34029541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
    Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
    Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, X-ray structure, physicochemical properties and anticancer activity of mer and fac Ru(iii) triphenylphosphine complexes with a benzothiazole derivative as a co-ligand.
    Richert M; Walczyk M; Cieślak MJ; Kaźmierczak-Barańska J; Królewska-Golińska K; Wrzeszcz G; Muzioł T; Biniak S
    Dalton Trans; 2019 Jul; 48(28):10689-10702. PubMed ID: 31241117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetically labile ruthenium(II) complexes of terpyridines and saccharin: effect of substituents on photoactivity, solvation kinetics, and photocytotoxicity.
    Kumar P; Singh P; Saren S; Pakira S; Sivakumar S; Patra AK
    Dalton Trans; 2021 Jun; 50(23):8196-8217. PubMed ID: 34031678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversible pH-Responsive Behavior of Ruthenium(II) Arene Complexes with Tethered Carboxylate.
    Martínez-Peña F; Infante-Tadeo S; Habtemariam A; Pizarro AM
    Inorg Chem; 2018 May; 57(9):5657-5668. PubMed ID: 29688005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes on non-small-cell lung cancer and triple negative breast cancer cells.
    Fayad C; Audi H; Khnayzer RS; Daher CF
    J Biol Inorg Chem; 2021 Feb; 26(1):43-55. PubMed ID: 33221954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polynuclear ruthenium organometallic complexes containing a 1,3,5-triazine ligand: synthesis, DNA interaction, and biological activity.
    Beckford FA; Niece MB; Lassiter BP; Beebe SJ; Holder AA
    J Biol Inorg Chem; 2018 Dec; 23(8):1205-1217. PubMed ID: 30039184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the structural determinants for anticancer activity of a ruthenium arene peptide conjugate.
    Meier SM; Novak M; Kandioller W; Jakupec MA; Arion VB; Metzler-Nolte N; Keppler BK; Hartinger CG
    Chemistry; 2013 Jul; 19(28):9297-307. PubMed ID: 23712572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin "Drug" Stabilized in Oxidovanadium(IV)-BODIPY Conjugates for Mitochondria-Targeted Photocytotoxicity.
    Bhattacharyya U; Kumar B; Garai A; Bhattacharyya A; Kumar A; Banerjee S; Kondaiah P; Chakravarty AR
    Inorg Chem; 2017 Oct; 56(20):12457-12468. PubMed ID: 28972748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, interaction with DNA and antiproliferative activities of two novel Cu(II) complexes with norcantharidin and benzimidazole derivatives.
    Song WJ; Lin QY; Jiang WJ; Du FY; Qi QY; Wei Q
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():122-8. PubMed ID: 25218220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.